0 • 0 Ratings
🗓️ 10 April 2023
⏱️ 34 minutes
🧾️ Download transcript
SOUNDS OF SCIENCE - EPISODE 15
On today’s episode, we focus on the EU’s Medical Device Regulation (MDR) which came into full effect on 26 May 2021 and followed by the In Vitro Diagnostic Device Regulation (IVDR) the following year. The idea of both regulations is to balance the regulatory review and approval processes of medical devices and IVDs across all EU Member States, essentially harmonizing the European market for medical devices.
However, the Medical Device Regulation is causing some problems, and stakeholders and politicians at both the national and EU levels are warning that the MDR is leading to potential medical device shortages, and even medical devices disappearing from the EU market as a whole.
In short, the main problem is that under the MDR, all medical devices produced in Europe must be re-certified. Re-certification needs to be done by a notified body, which is a national organisation designated by an EU country to assess the conformity of devices placed on the market. The main reason for the shortages is the capacity of these notified bodies to recertify. There are currently only 36 notified bodies with 23,000 certificates that need to transfer very much at the same time. Also, most manufacturers are not prepared for the new and sometimes costly rules of the MDR.
In light of all this, and primarily to prevent the imminent risk of shortages, the European Commission decided to amend the medical device and in vitro diagnostic regulations. To help us breakdown the recent changes and what it means for EU medical device companies, we’re joined by three experts in the medical devices space:
---------------------------------------------------------------------------------
If you're a medical device company looking to add your voice to the ongoing debate and need help navigating the complex EU medical device market, please reach out to EUCOPE's Leander Vranken ([email protected]) to learn how to join our MDR/IVDR Focus Group.
Click on a timestamp to play from that location
0:00.0 | So hello everybody and welcome to Yukoops Sounds of Science, a series of podcast hosted by |
0:10.2 | Yukope, a European trade body representing small and mid-sized companies active in health |
0:15.2 | technologies. My name is Leandro Franke, policy officer at Yukope as well as your host on today's |
0:20.6 | episode. |
0:21.5 | Before moving forward, we'd like to kindly ask you to click on the subscribe button for a podcast |
0:25.9 | and follow us on Twitter and LinkedIn to stay up to date on all of the latest news and |
0:30.9 | initiatives within the world of European life sciences. |
0:37.8 | On today's episode, we're going to talk about the EU's medical device regulation |
0:42.3 | that came into full effect in May 2021 and was later followed by the in vitro |
0:47.9 | diagnostic device regulations in 2022. Basically, in Europe, the medical devices regulation governs the production and distribution |
0:56.3 | of medical devices, while the in vitro regulation governs the sales and productions of |
1:01.7 | in vitro diagnostic medical devices. Essentially, the idea of both regulations is really |
1:07.3 | to harmonize the regulatory review and approval processes of medical and diagnostic devices all across Europe, |
1:14.7 | basically harmonizing the European market for medical devices. |
1:18.7 | And here at UKOP, we are of course always very much in support of improving regulatory efficiency, |
1:23.9 | especially in relation to safety. |
1:27.3 | However, the implementation of both the medical device regulation, or MDR, as it is abbreviated, |
1:33.8 | and the in-vito diagnostic regulation or IVDR have been causing quite some problems lately. |
1:40.2 | Several stakeholders, also including UKOP, but also other associations and national and EU-level |
1:46.5 | policymakers have warned that both the MDR and IVDR could lead to severe shortages of |
1:53.2 | medical devices and medical tests in Europe. |
1:56.6 | These are really key to prevent, but also diagnose and treat severe diseases. So what seems to be the |
... |
Please login to see the full transcript.
Disclaimer: The podcast and artwork embedded on this page are from EUCOPE, and are the property of its owner and not affiliated with or endorsed by Tapesearch.
Generated transcripts are the property of EUCOPE and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.
Copyright © Tapesearch 2025.